President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget
In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online
News Analysis: IOM Report A Case Study In Communications Disaster
NCI Programs: Coleman To Lead NCI’s New Radiation Oncology Program
Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification
In Brief: Online Genetics Glossary; ORI Misconduct Finding
Trending Stories
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated